FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Novel Laboratories Lupin Hydrocodone Bitartrate and Homatropine Recall

Lupin Hydrocodone Bitartrate and Homatropine Methylbromide Tablets, USP 5/1

Novel Laboratories, Inc. · Somerset, NJ

Risk level
Class III
Reported by FDA
Mar 21, 2018
Recall ID
D-0599-2018
Check your lot numberHow we source this data

Summary

Novel Laboratories recalled Lupin Hydrocodone Bitartrate and Homatropine starting Mar 5, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0599-2018 on Mar 21, 2018. Reason: Failed Impurities/Degradation Specifications. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications

Product description

Lupin Hydrocodone Bitartrate and Homatropine Methylbromide Tablets, USP 5/1.5 mg Rx Only 30 Tablets Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-118-03 UPC 343386118038

Lot numbers, UPCs & expiration codes

M16002A (02/2018); M16246A (04/2018); M16246B (04/2018); M16434A (07/2018); M16569A (10/2018); M17015A (01/2019); S700271 (04/2019);

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0599-2018
Classification
Class III
Status
Terminated
Recall initiated
Mar 5, 2018
FDA report date
Mar 21, 2018
Quantity
134,364 bottles (4,030,920 tablets)
Recall type
Voluntary: Firm initiated
Recalling firm
Novel Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0599-2018, exactly as published.

Show all FDA fields
City
Somerset
State
NJ
Status
Terminated
Country
United States
Event ID
79298
Address
400 Campus Dr
Code information
M16002A (02/2018); M16246A (04/2018); M16246B (04/2018); M16434A (07/2018); M16569A (10/2018); M17015A (01/2019); S700271 (04/2019);
Postal code
08873-1145
Report date
Mar 21, 2018
Product type
Drugs
Recall number
D-0599-2018
Classification
Class III
Recalling firm
Novel Laboratories, Inc.
Product quantity
134,364 bottles (4,030,920 tablets)
Termination date
Jun 8, 2020
Reason for recall
Failed Impurities/Degradation Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lupin Hydrocodone Bitartrate and Homatropine Methylbromide Tablets, USP 5/1.5 mg Rx Only 30 Tablets Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-118-03 UPC 343386118038
Distribution pattern
Nationwide
Recall initiation date
Mar 5, 2018
Initial firm notification
Letter
Center classification date
Mar 14, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0599-2018, published Mar 21, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls